Erratum to “Clinical Study on Nicotinamide Phosphoribosyl Transferase and SIRT1 Level in Patients With Neutropenia After Chemotherapy for Lung Cancer” [Shimane J Med Sci, Vol. 38, pp. 119-125, 2021]

Yukari TSUBATA; Tomomi AKITA; Ryosuke TANINO; Takamasa HOTTA; Ayano TEZUKA; Misato KOBAYASHI; Takae OKUNO; Yohei SHIRATSUKI; Akari TANINO; Megumi HAMAGUCHI; Chikamasa YAMASHITA; Takeshi ISOBE

doi:10.51010/sjms.39.1_47

Erratum

Erratum to “Clinical Study on Nicotinamide Phosphoribosyl Transferase and SIRT1 Level in Patients With Neutropenia After Chemotherapy for Lung Cancer” [Shimane J Med Sci, Vol. 38, pp. 119-125, 2021]

Yukari TSUBATA , Tomomi AKITA, Ryosuke TANINO, Takamasa HOTTA, Ayano TEZUKA, Misato KOBAYASHI, Takae OKUNO, Yohei SHIRATSUKI, Akari TANINO, Megumi HAMAGUCHI, Chikamasa YAMASHITA, Takeshi ISOBE

著者情報

Yukari TSUBATA [日本] 責任著者
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Tomomi AKITA [日本]
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan [日本]
Ryosuke TANINO [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Takamasa HOTTA [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Ayano TEZUKA [日本]
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan [日本]
Misato KOBAYASHI [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Takae OKUNO [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Yohei SHIRATSUKI [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Akari TANINO [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Megumi HAMAGUCHI [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]
Chikamasa YAMASHITA [日本]
Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan [日本]
Takeshi ISOBE [日本]
Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan [日本]

ジャーナルオープンアクセス HTML

2022 年 39 巻 1 号 p. 47-

DOI https://doi.org/10.51010/sjms.39.1_47

J-STAGE : sjms 38 4 pp.119-125

詳細

Abstract

After publishing the above article, the publisher noticed that the table 1 legend was not printed correctly. We regret to inform you that we have made the following correction.

Patient number

N = 16

Median age (range)

68.5 (50-75)

Sex, male/female (%)

13(81.3) / 3(18.8)

ECOG PS (%)

5 (31.3)

10 (62.5）

1 (6.3)

Histology (%)

Adenocarcinoma

10 (62.5)

Squamous cell carcinoma

5 (31.1)

Adenosquamous carcinoma

1 (6.3)

Stage (%)

2 (12.5)

Postoperative setting

14 (87.5)

Chemotherapy regimen (n, %)

　CBDCA/S-1, CDDP/PEM/BEV (3, 18.8)

　CBDCA/PEM/BEV, CDDP/PEM, CDDP/GEM, CDDP/VNR (2, 12.5)

　CBDCA/PTX/BEV, CBDCA/nab-PTX (1, 6.3)

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）